Mylab introduces two rapid point-of-care tests for Dengue infection

Tests include Dengue Rapid Test and Dengue high accuracy Dry Luminescence Assay Test

0
96
Biovoice News Vaccine for Dengue
New Delhi: Dengue fever, a viral disease transmitted by mosquitoes, poses a significant public health challenge in India. Timely and accurate diagnosis of dengue is crucial to confirm suspected cases and ensure prompt disease management.
To meet the testing requirements for this virus, Mylab Discovery Solutions has introduced two state-of-the-art tests for the detection of Dengue infections: the Dengue rapid gold Test and the Dengue high accuracy Dry Luminescence Assay Test. These rapid point-of-care tests have been developed to meet the critical testing needs for Dengue infections in our country.
Key Features of Mylab’s Dengue rapid Gold Test and Dengue Dry Luminescence Assay Test include:
  • Differentiation of IgG and IgM Antibodies: The tests effectively differentiate between IgM and IgG antibodies, providing valuable insights into the stage and progression of the Dengue infection.
  • Rapid Point-of-Care Testing: Both tests offer rapid point-of-care capabilities, ensuring quick and on-the-spot diagnosis within 15-20 minutes without the need for laboratory setup or complex procedures.
  • Enhanced Sensitivity and Specificity: Mylab’s Dengue IgG/IgM Gold Test and Dengue IgG/IgM Dry Luminescence Assay Test are known for their high sensitivity and specificity, ensuring reliable and accurate results.
  • Timely Detection of Infections: Positive IgM and IgG test results indicate recent Dengue virus infections, allowing for timely intervention and proper patient care.
  • Easy-to-use- The tests can be used in resource-limited regions with a high prevalence of Dengue, to provide timely diagnosis and support Dengue screening programs.
Speaking about the launch of the Tests, Hasmukh Rawal, Co-founder & Managing Director of Mylab said, “The introduction of these Tests reinforces our commitment to combating the rise of Dengue cases in India. These rapid point-of-care tests provide healthcare professionals with accurate and efficient tools for timely diagnosis, ultimately aiding in effective disease management”.
Positive IgM and IgG tests for Dengue antibodies indicate recent infection with the dengue virus. In the case of primary dengue infection, detectable levels of IgM antibodies emerge as early as the 3rd day after infection and generally persist for 2-6 months. Following IgM, Dengue IgG antibodies appear around day 7 of the fever during the primary infection and remain present for an extended period, potentially lasting for years.
With the introduction of these advanced tests, Mylab aims to empower healthcare professionals with cutting-edge diagnostic tools to combat the rise of Dengue cases. The test kits will be available by the end of this month.